Webinar

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Format: External webinar | Document type: Webinar

This content is provided by Recipharm AB, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to address the different needs from supercoil plasmid and linear isoform
A platform approach with integrated processes and analytical toolboxes to accelerate plasmid development to manufacturing

Speaker

Jing Zhu Jing Zhu Vice President, Nucleic Acid & Viral Vector Technology
AAV Process Development

Related resources from Recipharm AB

Supplier info centre